These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32900806)

  • 1. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
    Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein.
    Diao J; Komura R; Sano T; Pantua H; Storek KM; Inaba H; Ogawa H; Noland CL; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Volny M; Liu P; Nickerson NN; Sandoval W; Austin CD; Murray J; Rutherford ST; Reichelt M; Xu Y; Xu M; Yanagida H; Nishikawa J; Reid PC; Cunningham CN; Kapadia SB
    J Bacteriol; 2021 Jun; 203(13):e0014921. PubMed ID: 33875545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.
    Xiao Y; Gerth K; Müller R; Wall D
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2014-21. PubMed ID: 22232277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in
    Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.
    Xiao Y; Wall D
    J Bacteriol; 2014 Mar; 196(6):1174-83. PubMed ID: 24391051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
    Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
    Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lspA gene, encoding the type II signal peptidase of Rickettsia typhi: transcriptional and functional analysis.
    Rahman MS; Ceraul SM; Dreher-Lesnick SM; Beier MS; Azad AF
    J Bacteriol; 2007 Jan; 189(2):336-41. PubMed ID: 17098907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LspA-independent action of globomycin on Mycobacterium tuberculosis.
    Banaiee N; Jacobs WR; Ernst JD
    J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic
    Diao J; Bouwman C; Yan D; Kang J; Katakam AK; Liu P; Pantua H; Abbas AR; Nickerson NN; Austin C; Reichelt M; Sandoval W; Xu M; Whitfield C; Kapadia SB
    mBio; 2017 May; 8(3):. PubMed ID: 28536290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IS
    Maybin M; Ranade AM; Schombel U; Gisch N; Mamat U; Meredith TC
    mBio; 2024 Jul; 15(7):e0063424. PubMed ID: 38904391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of globomycin analogs as novel gram-negative antibiotics.
    Garland K; Pantua H; Braun MG; Burdick DJ; Castanedo GM; Chen YC; Cheng YX; Cheong J; Daniels B; Deshmukh G; Fu Y; Gibbons P; Gloor SL; Hua R; Labadie S; Liu X; Pastor R; Stivala C; Xu M; Xu Y; Zheng H; Kapadia SB; Hanan EJ
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127419. PubMed ID: 32768648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type II signal peptidase of Legionella pneumophila.
    Geukens N; De Buck E; Meyen E; Maes L; Vranckx L; Van Mellaert L; Anné J; Lammertyn E
    Res Microbiol; 2006 Nov; 157(9):836-41. PubMed ID: 17005379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
    Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
    ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group IIA-Secreted Phospholipase A2 and Daptomycin.
    Kuijk MM; Wu Y; van Hensbergen VP; Shanlitourk G; Payré C; Lambeau G; Man-Bovenkerk S; Herrmann J; Müller R; van Strijp JAG; Pannekoek Y; Touqui L; van Sorge NM
    J Innate Immun; 2023; 15(1):333-350. PubMed ID: 36473432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.
    Brannon JR; Thomassin JL; Desloges I; Gruenheid S; Le Moual H
    FEMS Microbiol Lett; 2013 Aug; 345(1):64-71. PubMed ID: 23710656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci.
    Dang TN; Zhang L; Zöllner S; Srinivasan U; Abbas K; Marrs CF; Foxman B
    Infect Genet Evol; 2013 Oct; 19():212-8. PubMed ID: 23891665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains.
    Adamus-Białek W; Baraniak A; Wawszczak M; Głuszek S; Gad B; Wróbel K; Bator P; Majchrzak M; Parniewski P
    Mol Biol Rep; 2018 Oct; 45(5):1055-1065. PubMed ID: 30008141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The highly dynamic nature of bacterial heteroresistance impairs its clinical detection.
    Pereira C; Larsson J; Hjort K; Elf J; Andersson DI
    Commun Biol; 2021 May; 4(1):521. PubMed ID: 33953333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein signal peptidase of Streptococcus suis serotype 2.
    de Greeff A; Hamilton A; Sutcliffe IC; Buys H; van Alphen L; Smith HE
    Microbiology (Reading); 2003 Jun; 149(Pt 6):1399-1407. PubMed ID: 12777481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.